BrainXell, Inc.

BrainXell provides iPSC-derived human neurons to the pharmaceutical industry and other research organizations for CNS drug discovery and development. Utilizing proprietary technology developed over the last two decades by Professor Su-Chun Zhang at the University of Wisconsin, we generate subtype-specific neurons that rapidly mature. Additionally, custom neuron batches at small to very large scale can be produced from any iPSC or ESC line provided.